W

Wonbiogen Co Ltd
KOSDAQ:307280

Watchlist Manager
Wonbiogen Co Ltd
KOSDAQ:307280
Watchlist
Price: 2 165 KRW 1.41% Market Closed
Market Cap: ₩49.2B

Net Margin

19.2%
Current
Improving
by 2.3%
vs 3-y average of 16.9%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
19.2%
=
Net Income
₩6.6B
/
Revenue
₩34.4B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
19.2%
=
Net Income
₩6.6B
/
Revenue
₩34.4B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Wonbiogen Co Ltd
KOSDAQ:307280
49.2B KRW
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.8B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
186.8B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
137.1B USD
Loading...
US
Stryker Corp
NYSE:SYK
135.7B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.3B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.6B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.1B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.5B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.6B USD
Loading...
US
Resmed Inc
NYSE:RMD
36.8B USD
Loading...

Market Distribution

Higher than 92% of companies in Korea
Percentile
92st
Based on 2 632 companies
92st percentile
19.2%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Wonbiogen Co Ltd
Glance View

Market Cap
49.2B KRW
Industry
Health Care

Wonbiogen Co., Ltd. engages in the research and development of biocompatible medical materials. The company is headquartered in Gumi, Gyeongsangbuk-Do. The company went IPO on 2018-12-05. The firm provides medical products including dressing material used for lower leg ulcers, pressure ulcers and surgical wounds; dressing material for secretions absorption and wound area protection; fixing band for bandages, gauze, catheters, along with others.

Wonbiogen Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
19.2%
=
Net Income
₩6.6B
/
Revenue
₩34.4B
What is Wonbiogen Co Ltd's current Net Margin?

The current Net Margin for Wonbiogen Co Ltd is 19.2%, which is above its 3-year median of 16.9%.

How has Net Margin changed over time?

Over the last 3 years, Wonbiogen Co Ltd’s Net Margin has increased from 12.7% to 19.2%. During this period, it reached a low of 12% on Dec 31, 2022 and a high of 19.2% on Oct 30, 2025.

Back to Top